Condition: Neoplasms Prostate · Cancer of the Prostate · Sponsor: Urological Research Network, LLC
This serves as a registration trial. It aims to record short, intermediate, and long-term outcomes of patients treated with targeted laser ablation of biopsy confirmed prostate cancer. Outcomes will be categorized as: 1- Procedure Related, 2- Perioperative - Adverse Events that may occur within 90 days, 3-Oncologic: Recurrence of cancer in treatment area, de-novo tumors, conversion to radical surgery, radiation or cryoablation, emergence of metastasis, 4- Functional: Sexual and Urinary function following treatment
This description comes directly from the study's public registry record.
CIELO D GUERRA, BS · 305-515-9887 · CIELO@BESTUROLOGY.NET
LUANDA SIANO, PA · 305-822-7227 · LUANDA@BESTUROLOGY.NET
Always discuss trial participation with your own doctor first.
| Urological Research Network | Miami Lakes, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05241236